AstraZeneca in $560 m deal for respiratory firm

by Blogburger on June 10, 2013

LONDON (AP) — British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $ 560 million.
Yahoo! News – Top Stories

Comments on this entry are closed.

Previous post:

Next post: